Context Therapeutics has reported encouraging interim Phase 1 data for [...]

oryzon-iadademstat-aml-alice2-frida-eha-2026 Oryzon Genomics has reported updated Phase 1b data from [...]

Medicus Pharma has submitted an investigational new drug application in [...]

Vertex Pharmaceuticals has presented new Phase 3 data showing positive [...]

Poolbeg Pharma has presented two posters at the European Hematology [...]

Scenic Biotech has joined the Michael J. Fox Foundation’s LRRK2 [...]

Poolbeg Pharma has activated the first clinical site and begun [...]

China’s National Medical Products Administration has approved Shionogi’s Symproic for [...]

FDA has granted orphan drug designation to Tris Pharma’s investigational [...]

PhoreMost has unveiled its lead oncology programme, PMC-001, as the [...]